Oman
Diabetes country report 2011 — 2050
Number of adults (20–79 years) with diabetes in Oman (OM)
2011 | 138.4 thousand |
2024 | 412.3 thousand |
2050 | 813.4 thousand |
Oman is one of the 21 countries and territories in the IDF Middle-East and North Africa Region.
Data source(s) used for the diabetes estimates in adults:
- Al Riyami A, Elaty MA, Morsi M, Al Kharusi H, Al Shukaily W, Jaju S. Oman Med J. 2012 Sep;27(5):425-43. PMID:23074559
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | - | 138.4 | 412.3 | 813.4 |
Age-standardised prevalence of diabetes, % | - | 10.5 | 17.0 | 18.7 |
Proportion of people with undiagnosed diabetes, % | - | - | 50.0 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 206.1 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 465.8 | 700.4 |
Age-standardised prevalence of IFG, % | - | - | 14.9 | 15.0 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 148.8 | 197.4 | 334.9 |
Age-standardised prevalence of IGT, % | - | 9.6 | 6.8 | 7.4 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 704.0 | 625.0 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 10.1 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 297.1 | 473.1 |
Total diabetes-related health expenditure, ID million | - | - | 757.6 | 1,206.4 |
Diabetes-related health expenditure per person, USD | - | 763.0 | 720.6 | 581.6 |
Diabetes-related health expenditure per person, ID | - | - | 1,837.6 | 1,483.1 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 34,676.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 6,552.2 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | - | 1,810.3 | 3,131.4 | 4,667.1 |
Population of children and adolescents (0-19 y) | - | - | 1,602,413.5 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | - |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | - |
Population of children and adolescents (0-19 y) | - |